Biotech Stocks Are Squeezing Sam Gatlin September 10, 2024 From the Desk of Steve Strazza @SstrazzaLast week, we outlined a short squeeze in Phathom Pharmaceuticals $PHAT, which has been working for us.It doesn't seem like the market is finished squeezing the short sellers out of their biotechnology positions.Today, we're discussing yet another biotech stock that has a ridiculously high days-to-cover ratio and short interest.More importantly, the risk couldn't be more well-defined.So, we're stepping up to the plate and taking another swing at a short squeeze. You need to have a subscription to access this content in full. Log in or subscribe Share Article Filed Under: Premium, Stocks, ASC, Strazza, Freshly Squeezed, Sam